Company: Tilray, Inc. Symbol: TLRY Description: They are pioneering the future of medical cannabis research, cultivation, processing and distribution globally, and we intend to become a leader in the adult-use cannabis market in Canada once legalized. Trade Date: 7/19 Shares: 9.0 million Price Range: $14.00-$16.00 Underwriter(s): Cowen, Roth Capital, Northland Capital Terms Added: 7-9-18 Link[…]
Establishment Labs Holdings Inc. #IPO Preview $ESTA
Company: Establishment Labs Holdings Inc. Symbol: ESTA Description: They are a medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics and reconstruction market. Trade Date: 7/19 Shares: 3.125 million Price Range: $15.00-$17.00 Underwriter(s): Jefferies, Cowen, BTIG Terms Added: 7-9-18 Link to Prospectus Link to Retail Roadshow Business: They are[…]
Replimune Group #IPO Preview ($REPL)
Company: Replimune Group, Inc. Symbol: REPL Description: They are a clinical-stage biotechnology company committed to applying our leading expertise in the field of oncolytic immunotherapy to transform the lives of cancer patients. Trade Date: 7/20 Shares: 6.7 million Price Range: $14.00-$16.00 Underwriter(s): J.P. Morgan, Leerink Partners, BMO Capital Markets Terms Added: 7-10-18 Link to Prospectus[…]
Rubius Therapeutics #IPO Preview ($RUBY)
Company: Rubius Therapeutics, Inc. Symbol: RUBY Description: They are pioneering the development of a new class of medicines, Red Cell Therapeutics, or RCTs. Trade Date: 7/19 Shares: 9.53 million Price Range: $20.00-$22.00 Underwriter(s):J.P. Morgan, Morgan Stanley, Jefferies, Leerink Partners Terms Added: 7-9-18 Link to Prospectus Link to Retail Roadshow Business: They are pioneering the development of[…]
Constellation Pharmaceuticals #IPO Preview $CNST
Company: Constellation Pharmaceuticals, Inc. Symbol: CNST Description: They are a clinical-stage biopharmaceutical company using our expertise in epigenetics to discover and develop novel therapeutics that address serious unmet medical needs in patients with cancers associated with abnormal gene expression or drug resistance. Trade Date: 7/19 Shares: 5.34 million Price Range: $14.00-$16.00 Underwriter(s): J.P. Morgan, Jefferies,[…]
Allakos Inc #IPO Preview ($ALLK)
Company: Allakos Inc. Symbol: ALLK Description: They are are a clinical stage biotechnology company developing AK002, our wholly owned monoclonal antibody, for the treatment of various eosinophil and mast cell related diseases. Trade Date: 7/19 Shares: 6 million Price Range: $15.00-$17.00 Underwriter(s):Goldman Sachs, Jefferies Co-Manager(s): William Blair Terms Added: 7-9-18 Link to Prospectus Link to[…]
Crinetics Pharmaceuticals #IPO Preview
Company: Crinetics Pharmaceuticals, Inc. Symbol: CRNX Description: They are a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Trade Date: 7/18 Shares: 5.0 million Price Range: $15.00-$17.00 Underwriter(s): J.P. Morgan, Leerink Partners, Piper Jaffray Terms Added: 7-9-18 Link to Prospectus Link to[…]
FirstWestern Financial #IPO Preview ($MYFW)
Company: First Western Financial, Inc. Symbol: MYFW Description: First Western Financial, Inc. is a financial holding company headquartered in Denver, Colorado. Trade Date: 7/19 Shares: 1.85 million Price Range: $19.00-$21.00 Underwriter(s): Keefe Bruyette & Woods, Stephens, Sandler O’ Neill Terms Added: 7-9-18 Link to Prospectus Link to Retail Roadshow Business: First Western Financial, Inc. is a financial[…]
Coastal Financial Corporation ($CCB) #IPO Preview
Company: Coastal Financial Corporation Symbol: CCB Description: They are a bank holding company that operates through our wholly owned subsidiary, Coastal Community Bank. Trade Date: Week of 7/16 Shares: 2.72 million Price Range: $13.00-$15.00 Underwriter(s): Keefe Bruyette & Woods, Hovde Group Terms Added: 7-10-18 Link to Prospectus Link to Retail Roadshow Business: They are a bank[…]
IPO Pipeline Update: 6-22-18
IPO Boutique keeps apprised of the active pipeline. Currently there are 72 active IPOs in the pipeline as of June 15, 2018. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why “looks may be perceiving” when it comes to the IPO pipeline in this article. NEW FILINGS IPO Boutique[…]
IPO Weekly Recap: Biotech Bingo!
Place more than four decades of experience on your team. We use a combination of underwriter contacts, global sources and contacts at large institutional funds to provide the TRUEST picture of how an IPO is shaping up prior to its debut. We are on your team. Additionally, we provide comprehensive research to outline short and[…]
Weekly Secondary Performance Recap (6.22.18)
IPO BOUTIQUE is one of the few syndicate services that provides ratings on all secondary offerings (Spots, blocks, marketed). We use our database of historical performances, underwriter trends and more than 40 years of syndicate experience to give our clients a leg up. We meticulously keep records of our ratings. If interested please click below to[…]
UXIN Limited #IPO Preview ($UXIN)
Company: Uxin Limited Symbol: UXIN Description: They are the largest used car e-commerce platform in China in terms of both the number of transactions facilitated and total GMV in 2017, according to iResearch. Trade Date: 6/27 Shares: 38 million ADS Price Range: $10.50-$12.50 Underwriter(s): Morgan Stanley, Goldman Sachs (Asia) LLC, J.P. Morgan, CICC, China Renaissance[…]
Tricida, Inc. #IPO Preview ($TCDA)
Company: Tricida, Inc. Symbol: TCDA Description: Their goal is to slow the progression of chronic kidney disease, or CKD, through the treatment of metabolic acidosis. Trade Date: 6/28 Shares: 10.3 million Price Range: $16.00-$18.00 Underwriter(s): Goldman Sachs, J.P. Morgan, Cowen Terms Added: 6-18-18 Link to Prospectus Link to Retail Roadshow Business: They are a late-stage pharmaceutical[…]
Translate Bio, Inc. #IPO Preview ($TBIO)
Company: Translate Bio, Inc. Symbol: TBIO Description: They are a leading messenger RNA, or mRNA, therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction Trade Date: 6/28 Shares: 7.7 million Price Range: $12.00-$14.00 Underwriter(s): Citigroup, Leerink Partners, Evercore ISI Terms Added; 6-18-18 Link to Prospectus[…]
The LoveSac Company #IPO Preview ($LOVE)
Company: The Lovesac Company Symbol: LOVE Description: They are a technology driven, omni-channel company that designs, manufactures and sells unique, high quality furniture comprised of modular couches called Sactionals and premium foam beanbag chairs called Sacs. Trade Date: 6/27 Shares: 3 million Price Range: $13.00-$15.00 Underwriter(s): Roth Capital Partners Co-Manager: Craig Hallum Terms Added: 6-18-18[…]
Neuronetics, Inc. #IPO Preview ($STIM)
Company: Neuronetics, Inc. Symbol: STIM Description: They are a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorder Trade Date: 6/28 Shares: 5 million Price Range: $14.00-$16.00 Underwriter(s): Piper Jaffray, William Blair Co-Manager(s): Canaccord Genuity, BTIG, JMP Securities Terms[…]
Neon Therapeutics Inc #IPO Preview ($NTGN)
Company: Neon Therapeutics Symbol: NTGN Description: They are a clinical-stage immuno-oncology company and a leader in the field of neoantigen-targeted therapies, dedicated to transforming the treatment of cancer by directing the immune system towards neoantigens Trade Date: 6/27 Shares: 6.25 million Price Range: $15.00-$17.00 Underwriter(s): Morgan Stanley, BofA Merrill Lynch, Mizuho Securities Co-Manager(s): Oppenheimer &[…]
GoodBulk Ltd. #IPO Preview ($GBLK)
Company: Forty Seven, Inc. Symbol: FTSV Description: They are GoodBulk Ltd., a leading international owner and operator of dry bulk vessels, and one of the world’s largest owners of Capesize vessels. Trade Date: 6/28 Shares: 6.7 million Price Range: $14.00-$16.00 Underwriter(s): Morgan Stanley, Credit Suisse Co-Manager(s): BTIG, Canaccord Genuity, Oppenheimer& Co. Terms Added: 6-18-18 Link[…]
Forty Seven Inc. (FTSV) #IPO Preview
Company: Forty Seven, Inc. Symbol: FTSV Description: They are a clinical-stage immuno-oncology company focused on developing novel checkpoint therapies to activate macrophages in the fight against cancer. Trade Date: 6/28 Shares: 6.7 million Price Range: $14.00-$16.00 Underwriter(s): Morgan Stanley, Credit Suisse Co-Manager(s): BTIG, Canaccord Genuity, Oppenheimer & Co. Terms Added: 6-18-18 Link to Prospectus Link[…]